Medicare Drug Price Negotiations in 2026: What the New Prices Mean for Patients
In 2026, Medicare beneficiaries are seeing the first real-world effects of negotiated drug prices and a new $2,000 annual out-of-pocket cap under Part D. Here’s what changed, which drugs are affected, and what to check with your plan.
